News update

Tangley, Laura
July 1987
BioScience;Jul/Aug87, Vol. 37 Issue 7, p461
Academic Journal
Provides news briefs regarding life science research as of July 1987. How researchers at the University of California have tested genetically altered bacteria that is designed to reduce frost damage to crops; Announcement from the U.S. Patent and Trademark Office that it will permit patenting of nonnaturally occurring non-human multicellular living organisms; Use of biotechnology to improve cereal crops; Others.


Related Articles

  • Catalysis for Life Sciences Makes Advances. Scott, Alex // Chemical Week;5/2/2007, Vol. 169 Issue 15, p29 

    The article reports on the developments in chiral catalytic processes used in life science applications. The increasing commercial use of biocatalytic systems is due in part to the adoption of directed evolution technologies which involve taking bacteria and controlling evolution of the enzyme...

  • "Like playing chess with no squares". Dietderich, Andrew // Crain's Detroit Business;6/5/2006, Vol. 22 Issue 23, p13 

    The article analyzes the potential of Michigan to become a biotech powerhouse. It is not an easy task for a state built on automotive and manufacturing capabilities to become a biotech powerhouse. When California-based think tank Milken Institute studied the major areas of biotech and life...

  • Heating as a rapid purification method for recovering correctly-folded thermotolerant VH and VHH domains. Olichon, Aurelien; Schweizer, Daniel; Muyldermans, Serge; Marco, Ario de // BMC Biotechnology;2007, Vol. 7, p7 

    Background: Recombinant antibodies from Camelidae (VHHs) are potentially useful tools for both basic research and biotechnological applications because of their small size, robustness, easy handling and possibility to refold after chemio-physical denaturation. Their heat tolerance is a...

  • World's first for continuous purification of antibodies.  // Checkout;Jun2015, Vol. 41 Issue 6, Special section p44 

    The article reports that scientists at the Austrian Centre of Industrial Biotechnology (acib) and the University of Natural Resources Vienna (BOKU) have come up with downstream processing method for recombinant antibodies from Chinese hamster ovary cells (CHO) that could reduce production costs.

  • Controversial biological and gene patent Bill delayed.  // Australian Life Scientist;6/17/2011, p1 

    The Senate has issued an extension until August for the hotly debated Patent Amendment (Human Genes and Biological Materials) Bill.

  • Indian biotechnology-rapidly evolving and industry led. Thorsteinsdóttir, Halla; Quach, Uyen; Daar, Abdallah S; Singer, Peter A; Kumar, Nandini K; Somsekhar, Hemlatha // Nature Biotechnology;Dec2004 Supplement 12, Vol. 22, pDC31 

    The article focuses on the health biotechnology sector in India. One of the biggest success was first indigenously developed hepatitis B vaccine, a recombinant form of hepatitis B surface antigen produced in Pichia pastoris and manufactured under the name Shanvac-B. Indigenous production of...

  • B-TECH UPDATE. Thomas III, Calhoun "Reb" // SciTech Lawyer;Winter2009, Vol. 5 Issue 3, p26 

    The article provides updates on legislative, judicial and public policy issues concerning the science and technology areas of biotechnology, pharmacy, and life sciences. The BioBricks Foundation (BBF) has encouraged the development and use of technologies based on deoxyribonucleic acid (DNA)...

  • Bioethics in biomedicine in the context of a global higher education area. Liras, Antonio; Arenas, Alicia // International Archives of Medicine;2010, Vol. 3, p10 

    The University is tasked with drawing together, transmitting and maintaining knowledge, while creating an area where the ethical "sense" required for working in the field of Biology and Biomedicine can be provided. Although scientific knowledge is present on an overwhelming scale in nature and,...

  • Introduction: promoting global health through biotechnology. Thorsteinsdóttir, Halla; Quach, Uyen; Daar, Abdallah S; Singer, Peter A; Martin, Douglas K // Nature Biotechnology;Dec2004 Supplement 12, Vol. 22, pDC3 

    The article focuses on a study related to the success of the health biotechnology sector in developing countries. Seven countries were chosen as follows; South Korea, Cuba, Brazil, China, South Africa, Egypt and India. Innovations of developing countries in health biotechnology includes...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics